Skip to main content
OpenTrials

Clinical trial condition

Stage IV Pancreatic Cancer

Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

70 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer trial results

Completed

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

NCT02333188

Conditions
Adenocarcinoma, Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, +35 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University Health System Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer

NCT01647828

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Western Regional Medical Center, Inc. Goodyear, Arizona, United States
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • St Jude Heritage Healthcare Virginia K. Crosson Cancer Center Fullerton, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
View all 26 locations
View Trial Details
Completed

Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

NCT03412799

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Scripps MD Anderson Cancer Center La Jolla, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Blacktown Cancer & Haematology Centre Blacktown, New South Wales, Australia
View Trial Details
Completed

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00617708

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Mills - Peninsula Hospitals Burlingame, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 146 locations
View Trial Details

Related conditions